These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30273036)

  • 1. Provider Payments And The Receipt Of Human Papillomavirus Vaccine Among Privately Insured Adolescents.
    Tsai Y; Lindley MC; Zhou F; Stokley S
    Health Aff (Millwood); 2018 Oct; 37(10):1587-1595. PubMed ID: 30273036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.
    Adjei Boakye E; Tobo BB; Osazuwa-Peters N; Mohammed KA; Geneus CJ; Schootman M
    Am J Prev Med; 2017 Jun; 52(6):742-752. PubMed ID: 27890518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.
    Saxena K; Kathe N; Sardana P; Yao L; Chen YT; Brewer NT
    Hum Vaccin Immunother; 2023 Dec; 19(1):2161253. PubMed ID: 36631995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance reimbursements for human papillomavirus vaccination in the private sector, 2007-2014.
    Tsai Y; Lindley MC; Zhou F; Stokley S
    Prev Med Rep; 2019 Sep; 15():100917. PubMed ID: 31223560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Uptake of Human Papillomavirus Vaccine Among Postpartum Women, 2006-2012.
    Kilfoyle KA; Rahangdale L; Dusetzina SB
    J Womens Health (Larchmt); 2016 Dec; 25(12):1256-1261. PubMed ID: 27447054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012.
    Dunne EF; Stokley S; Chen W; Zhou F
    J Adolesc Health; 2015 Apr; 56(4):408-13. PubMed ID: 25797632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009.
    Hirth JM; Tan A; Wilkinson GS; Berenson AB
    Vaccine; 2013 Feb; 31(8):1138-40. PubMed ID: 23290834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination.
    Mohanty S; Leader AE; Gibeau E; Johnson C
    Vaccine; 2018 Sep; 36(40):5955-5961. PubMed ID: 30172634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.
    McLean HQ; VanWormer JJ; Chow BDW; Birchmeier B; Vickers E; DeVries E; Meyer J; Moore J; McNeil MM; Stokley S; Gee J; Belongia EA
    J Adolesc Health; 2017 Aug; 61(2):252-258. PubMed ID: 28462786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of insurance, income, and affordability in human papillomavirus vaccination.
    Pourat N; Jones JM
    Am J Manag Care; 2012 Jun; 18(6):320-30. PubMed ID: 22775000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany.
    Rieck T; Feig M; Deleré Y; Wichmann O
    Vaccine; 2014 Sep; 32(43):5564-9. PubMed ID: 25131739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent-Parent Dyad Descriptions of the Decision to Start the HPV Vaccine Series.
    Chang J; Ipp LS; de Roche AM; Catallozzi M; Breitkopf CR; Rosenthal SL
    J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):28-32. PubMed ID: 29037930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
    Hirth JM; Tan A; Wilkinson GS; Berenson AB
    Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and Facilitators of HPV Vaccination in the VFC Program.
    Fleming WS; Sznajder KK; Nepps M; Boktor SW
    J Community Health; 2018 Jun; 43(3):448-454. PubMed ID: 29299729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.
    Schluterman NH; Terplan M; Lydecker AD; Tracy JK
    Vaccine; 2011 May; 29(21):3767-72. PubMed ID: 21440038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients.
    Spencer JC; Brewer NT; Trogdon JG; Wheeler SB; Dusetzina SB
    Am J Public Health; 2018 Jul; 108(7):946-950. PubMed ID: 29771616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccination in commercially-insured vaccine-eligible males and females, United States, 2007-2014.
    Gargano JW; Zhou F; Stokley S; Markowitz LE
    Vaccine; 2018 May; 36(23):3381-3386. PubMed ID: 29735321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.